<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03839992</url>
  </required_header>
  <id_info>
    <org_study_id>MHS #843-18</org_study_id>
    <nct_id>NCT03839992</nct_id>
  </id_info>
  <brief_title>Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis</brief_title>
  <official_title>The Measurement and Analysis of Maximal Expiratory Flow Volume Loops at Low Lung Volumes in Children With Cystic Fibrosis and Normal Routine Lung Function.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gelb, Arthur F., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gelb, Arthur F., M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Goal is to physiologically detect unsuspected small airways obstruction in children and
      adults with treated heterozygous and homozygous cystic fibrosis. Unsuspected refers to normal
      routine pre bronchodilator spirometry including normal FEV1(L), FVC (L). and FEV1/FVC%. This
      is a retrospective study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current study is based on current investigators previously published patho-physiologic
      and lung CT studies in small airways intrinsic obstruction, emphysema, and asthma. Current
      investigators have demonstrated that despite the presence of normal routine spirometry
      including normal FEV1(L), FVC (L), and FEV1/FVC% that unsuspected small airways obstruction,
      and emphysema can be detected. This has been achieved by presence of isolated abnormal
      expiratory airflow limitation at low lung volumes on the maximal expiratory flow volume
      curves. This includes abnormal expiratory airflow at 75% and 80% expired lung volume. Current
      investigators believe investigators will be able to detect unsuspected small airways
      intrinsic obstruction, and peripheral airway bronchiectasis proven by lung CT, in patients
      with cystic fibrosis despite presence of pre bronchodilator normal routine spirometry.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 25, 2018</start_date>
  <completion_date type="Anticipated">April 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of Unsuspected Small Airway Obstruction in Cystic Fibrosis</measure>
    <time_frame>2 years</time_frame>
    <description>Retrospective analysis of pre bronchodilator spirometry, and lung CT study to detect abnormal FEF75% in the presence of normal spirometry and FEF25-75. Detect isolated abnormal pre bronchodilator spirometry at 75%FVC</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cystic Fibrosis in Children</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>spirometry</intervention_name>
    <description>measure spirometry and lung CT</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Review pulmonary function and radiologic studies in retrospective records of heterozygote
        or homozygote patients with cystic fibrosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Heterozygote or homozygote patients with cystic fibrosis with normal routine pre
        bronchodilator spirometry including normal FEV1(L), FVC(L) and FEV1/FVC%.

        Exclusion Criteria:Heterozygote or homozygote patients with cystic fibrosis with ABNORMAL
        routine pre bronchodilator spirometry

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arthur Gelb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arthur F Gelb, MD</last_name>
    <phone>562-565-5333</phone>
    <phone_ext>5625655333</phone_ext>
    <email>afgelb@msn.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vicki Masson, MD</last_name>
    <phone>631-741-0549</phone>
    <phone_ext>5625655333</phone_ext>
    <email>vicki.masson@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Miller Children`s Hospital and Long Beach Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicki C Masson, MD</last_name>
      <phone>631-741-0549</phone>
      <phone_ext>6317410549</phone_ext>
      <email>vicki.masson@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Eli C Nussbaum, MD</last_name>
      <phone>714-356-6830</phone>
      <phone_ext>6317410549</phone_ext>
      <email>ENussbaum@memorialcare.org</email>
    </contact_backup>
    <investigator>
      <last_name>Vicki C Masson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Mead J. The lung's &quot;quiet zone&quot;. N Engl J Med. 1970 Jun 4;282(23):1318-9.</citation>
    <PMID>5442364</PMID>
  </results_reference>
  <results_reference>
    <citation>Gelb AF, Gold WM, Wright RR, Bruch HR, Nadel JA. Physiologic diagnosis of subclinical emphysema. Am Rev Respir Dis. 1973 Jan;107(1):50-63.</citation>
    <PMID>4683321</PMID>
  </results_reference>
  <results_reference>
    <citation>Gelb AF, Zamel N. Simplified diagnosis of small-airway obstruction. N Engl J Med. 1973 Feb 22;288(8):395-8.</citation>
    <PMID>4684043</PMID>
  </results_reference>
  <results_reference>
    <citation>Hogg JC, Par√© PD, Hackett TL. The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease. Physiol Rev. 2017 Apr;97(2):529-552. doi: 10.1152/physrev.00025.2015. Review. Erratum in: Physiol Rev. 2018 Jul 1;98(3):1909.</citation>
    <PMID>28151425</PMID>
  </results_reference>
  <results_reference>
    <citation>Lukic KZ, Coates AL. Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma? Pediatr Pulmonol. 2015 Sep;50(9):863-8. doi: 10.1002/ppul.23234. Epub 2015 Jun 16.</citation>
    <PMID>26079395</PMID>
  </results_reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 11, 2019</study_first_submitted>
  <study_first_submitted_qc>February 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>February 20, 2019</last_update_submitted>
  <last_update_submitted_qc>February 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>abnormal FEF75</keyword>
  <keyword>bronchiectasis</keyword>
  <keyword>lung CT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All individual published data will be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>when published</ipd_time_frame>
    <ipd_access_criteria>published data</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

